Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
$1.74
-1.1%
$1.85
$1.52
$46.80
$4.29M-3.6314,312 shs41,680 shs
IRIDEX Co. stock logo
IRIX
IRIDEX
$0.94
-3.8%
$1.03
$0.78
$2.58
$15.83M0.6947,421 shs45,591 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$1.21
-1.6%
$1.64
$0.53
$4.49
$20.79M4.671.24 million shs35,646 shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$0.19
$0.22
$0.16
$1.49
$16.41M0.251.21 million shs978,062 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
-1.14%-2.79%-16.35%-38.73%-96.28%
IRIDEX Co. stock logo
IRIX
IRIDEX
-3.78%-7.55%-22.70%-31.17%-61.51%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-1.63%-1.63%-33.88%-55.02%+19.80%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
0.00%-1.35%-12.72%-37.31%-82.81%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
2.7501 of 5 stars
3.52.00.00.03.31.71.3
IRIDEX Co. stock logo
IRIX
IRIDEX
0.749 of 5 stars
0.04.00.00.02.61.70.0
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.4627 of 5 stars
3.55.00.00.03.83.30.0
Beyond Air, Inc. stock logo
XAIR
Beyond Air
4.3224 of 5 stars
3.53.00.03.52.72.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
3.00
Buy$16.50848.28% Upside
IRIDEX Co. stock logo
IRIX
IRIDEX
0.00
N/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.00
Buy$5.00313.22% Upside
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.00
Buy$1.50689.47% Upside

Current Analyst Ratings Breakdown

Latest AMIX, IRIX, NXL, and XAIR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/29/2025
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$5.00
3/24/2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$5.00
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
N/AN/AN/AN/A$8.12 per shareN/A
IRIDEX Co. stock logo
IRIX
IRIDEX
$48.80M0.32N/AN/A$0.59 per share1.60
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$131.07K158.59N/AN/A$0.43 per share2.81
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$3.02M5.43N/AN/A$0.27 per share0.70
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
-$15.43M-$12.93N/AN/AN/AN/A-212.48%-161.13%N/A
IRIDEX Co. stock logo
IRIX
IRIDEX
-$9.57M-$0.43N/AN/A-22.79%-192.95%-33.97%8/6/2025 (Estimated)
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$4.65M-$0.83N/AN/A-3,407.98%-187.59%-167.21%N/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$60.24M-$1.06N/AN/AN/A-1,730.00%-226.01%-109.75%6/23/2025 (Estimated)

Latest AMIX, IRIX, NXL, and XAIR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/23/2025Q4 2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$0.14N/AN/AN/A$1.39 millionN/A
5/13/2025Q1 2025
IRIDEX Co. stock logo
IRIX
IRIDEX
-$0.10-$0.10N/A-$0.10$12.10 million$11.90 million
5/13/2025Q1 2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 million
3/27/2025Q4 2024
IRIDEX Co. stock logo
IRIX
IRIDEX
-$0.05-$0.05N/A-$0.05$12.80 million$12.70 million
3/14/2025Q4 2024
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A-$0.28N/A-$0.28N/A$0.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
N/AN/AN/AN/AN/A
IRIDEX Co. stock logo
IRIX
IRIDEX
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
N/A
5.31
5.31
IRIDEX Co. stock logo
IRIX
IRIDEX
0.55
1.54
0.85
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
16.42
15.89
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/A
3.56
3.12

Institutional Ownership

CompanyInstitutional Ownership
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
10.78%
IRIDEX Co. stock logo
IRIX
IRIDEX
20.10%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
31.50%

Insider Ownership

CompanyInsider Ownership
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
32.40%
IRIDEX Co. stock logo
IRIX
IRIDEX
7.30%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
24.00%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
19.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
12.46 million1.67 millionN/A
IRIDEX Co. stock logo
IRIX
IRIDEX
12016.79 million15.42 millionOptionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
317.18 million10.11 millionNot Optionable
Beyond Air, Inc. stock logo
XAIR
Beyond Air
7086.37 million54.97 millionOptionable

Recent News About These Companies

Beyond Air granted U.S. patent for gaseous nitric oxide delivery
Beyond Air Gets Patent for Lung Infection Treatment
JonesTrading Sticks to Their Buy Rating for Beyond Air (XAIR)
Beyond Air subsidiary NeuroNOS announces publication of research
Beyond Air announces VUMC as first luminary site

New MarketBeat Followers Over Time

Media Sentiment Over Time

Autonomix Medical stock logo

Autonomix Medical NASDAQ:AMIX

$1.74 -0.02 (-1.14%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$1.81 +0.07 (+4.02%)
As of 08:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

IRIDEX stock logo

IRIDEX NASDAQ:IRIX

$0.94 -0.04 (-3.78%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$0.98 +0.04 (+4.35%)
As of 05/27/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$1.21 -0.02 (-1.63%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$1.24 +0.03 (+2.56%)
As of 07:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Beyond Air stock logo

Beyond Air NASDAQ:XAIR

$0.19 0.00 (0.00%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$0.19 0.00 (0.00%)
As of 08:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.